IMMUNIC, INC. Quarterly Return On Equity in % from Q3 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immunic, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q2 2024.
  • Immunic, Inc. Return On Equity for the quarter ending June 30, 2024 was -170 %, a 28.1% decline year-over-year.
  • Immunic, Inc. annual Return On Equity for 2023 was -157 %, a 59.6% decline from 2022.
  • Immunic, Inc. annual Return On Equity for 2022 was -98.6 %, a 40.8% decline from 2021.
  • Immunic, Inc. annual Return On Equity for 2021 was -70.1 %, a 79.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -170 -37.2 -28.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -170 -57 -50.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -157 -58.8 -59.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -159 -91.5 -135% Jul 1, 2023 Sep 30, 2023
Q2 2023 -133 -70.8 -115% Apr 1, 2023 Jun 30, 2023
Q1 2023 -113 -53.5 -89.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -98.6 -28.6 -40.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -67.9 -8.89 -15.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -61.8 -9 -17% Apr 1, 2022 Jun 30, 2022
Q1 2022 -59.6 -7.53 -14.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -70.1 -31 -79.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -59 -12.7 -27.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.8 +5.01 +8.67% Apr 1, 2021 Jun 30, 2021
Q1 2021 -52.1 +13.4 +20.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.1 +39.2 +50.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -46.3 +89.5 +65.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -57.8 +725 +92.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -65.5 -138 -191% Jan 1, 2020 Mar 31, 2020
Q4 2019 -78.3 -135 -237% Oct 1, 2019 Dec 31, 2019
Q3 2019 -136 -260 -209% Jul 1, 2019 Sep 30, 2019
Q2 2019 -783 +119 +13.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 72.2 +229 Jan 1, 2019 Mar 31, 2019
Q4 2018 56.9 +158 Oct 1, 2018 Dec 31, 2018
Q3 2018 124 +195 Jul 1, 2018 Sep 30, 2018
Q2 2018 -902 -835 -1264% Apr 1, 2018 Jun 30, 2018
Q1 2018 -157 -95 -154% Jan 1, 2018 Mar 31, 2018
Q4 2017 -101 -42 -71.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -70.8 -19 -36.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -66.1 -9.86 -17.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -61.8 +3.12 +4.81% Jan 1, 2017 Mar 31, 2017
Q4 2016 -58.9 +11.8 +16.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -51.7 +20.7 +28.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -56.2 +12.8 +18.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -64.9 -5.42 -9.11% Jan 1, 2016 Mar 31, 2016
Q4 2015 -70.7 +22 +23.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -72.5 +204 +73.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -69 Apr 1, 2015 Jun 30, 2015
Q1 2015 -59.5 Jan 1, 2015 Mar 31, 2015
Q4 2014 -92.7 Oct 1, 2014 Dec 31, 2014
Q3 2014 -277 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.